Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - TETRAPHASE PHARMACEUTICALS INC | ttph-ex322_9.htm |
| 10-K - 10-K - TETRAPHASE PHARMACEUTICALS INC | ttph-10k_20191231.htm |
| EX-32.1 - EX-32.1 - TETRAPHASE PHARMACEUTICALS INC | ttph-ex321_10.htm |
| EX-31.2 - EX-31.2 - TETRAPHASE PHARMACEUTICALS INC | ttph-ex312_12.htm |
| EX-31.1 - EX-31.1 - TETRAPHASE PHARMACEUTICALS INC | ttph-ex311_6.htm |
| EX-21.1 - EX-21.1 - TETRAPHASE PHARMACEUTICALS INC | ttph-ex211_8.htm |
| EX-10.20 - EX-10.20 - TETRAPHASE PHARMACEUTICALS INC | ttph-ex1020_706.htm |
| EX-4.10 - EX-4.10 - TETRAPHASE PHARMACEUTICALS INC | ttph-ex410_680.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
|
|
(1) |
Registration Statements (Forms S-8 No. 333-232161 and 333-198098) pertaining to the 2014 Employee Stock Purchase Plan of Tetraphase Pharmaceuticals, Inc., as amended, |
|
|
(2) |
Registration Statements (Forms S-8 No. 333-230364 and 333-209991) pertaining to the 2013 Stock Incentive Plan and Inducement Stock Option Awards of Tetraphase Pharmaceuticals, Inc., |
|
|
(3) |
Registration Statements (Forms S-8 No. 333-223985, 333-216742, 333-202576, and 333-194125) pertaining to the 2013 Stock Incentive Plan of Tetraphase Pharmaceuticals, Inc., |
|
|
(4) |
Registration Statement (Form S-8 No. 333-189361) pertaining to the 2006 Stock Incentive Plan and the 2013 Stock Incentive Plan of Tetraphase Pharmaceuticals, Inc., and |
|
|
(5) |
Registration Statements (Forms S-3 No. 333-222699, 333-218816, 333-214500, 333-202613, and No. 333-195631) of Tetraphase Pharmaceuticals, Inc. |
of our report dated March 11, 2020, with respect to the consolidated financial statements of Tetraphase Pharmaceuticals, Inc. included in this Annual Report (Form 10-K) of Tetraphase Pharmaceuticals, Inc. for the year ended December 31, 2019.
|
/s/ Ernst & Young LLP |
|
|
|
Boston, Massachusetts |
|
March 11, 2020 |